Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2018 06:00 ET | Source: Athersys, Inc.

Athersys CEO to Speak at the 2018 Brain Health Summit

CLEVELAND, Ohio, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will be a speaker and panelist at the 2018 Brain Health...
November 15, 2017 10:05 ET | Source: Athersys, Inc.

HEALIOS Announces Enrollment of First Patient in Japan in TREASURE Study of MultiStem® Treatment for Ischemic Stroke

CLEVELAND, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that its partner, HEALIOS K.K. (“Healios”), has enrolled the first patient in its study in Japan evaluating...
November 08, 2017 16:03 ET | Source: Athersys, Inc.

Athersys Reports Third Quarter 2017 Results

CLEVELAND, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended September 30, 2017. Highlights of the third quarter of...
October 11, 2017 06:00 ET | Source: Athersys, Inc.

Athersys and Nikon CeLL Innovation to Collaborate on MultiStem® Commercial Manufacturing in Japan

CLEVELAND, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced that it has entered into a manufacturing services agreement with Nikon CeLL innovation Co., Ltd. (NCLi) for...
October 09, 2017 10:00 ET | Source: Athersys, Inc.

Athersys to Host Third Quarter Financial Results Call

CLEVELAND, Oct. 09, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its third quarter 2017 financial results at approximately 4:00 PM Eastern Time on Wednesday, November 8, 2017,...
October 05, 2017 07:00 ET | Source: Athersys, Inc.

Athersys to Present at 2017 Cell & Gene Meeting on the Mesa and Announces Regenerative Medicine Advanced Therapy (RMAT) Designation From FDA

CLEVELAND, Oct. 05, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Robert W. Mays, Ph.D., Vice President, Regenerative Medicine and Head of Neuroscience Programs, will...
August 09, 2017 16:05 ET | Source: Athersys, Inc.

Athersys Reports Second Quarter 2017 Results

CLEVELAND, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended June 30, 2017. Highlights of the second quarter of 2017...
August 07, 2017 06:00 ET | Source: Athersys, Inc.

Athersys Reports Alignment of Key Regulators for Pivotal Registration Study in Stroke

MultiStem® stem cell technology receives Positive Opinion from European Medicines Agency Adds to Special Protocol Assessment and Fast Track designation in U.S., and Priority Review under Sakigake...
July 10, 2017 10:00 ET | Source: Athersys, Inc.

Athersys to Host Second Quarter Financial Results Call

CLEVELAND, July 10, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its second quarter 2017 financial results at approximately 4:00 PM Eastern Time on Wednesday, August 9, 2017,...
May 09, 2017 16:05 ET | Source: Athersys, Inc.

Athersys Reports First Quarter 2017 Results

Company announces Fast Track Designation by FDA for Stroke Program and other progress Management to host conference call at 4:30pm EDT todayCLEVELAND, May 09, 2017 (GLOBE NEWSWIRE) --...